Alzheimers drug controversy, page-3

yes if only the baseline controls hadn’t miraculously shown improvement which confounded the results. I still had hope for it, given dose group had shown improvement. Topline results were much better than biogens aducanumab ( Aduhelm) but that dreaded partial clinical hold came. Im disappointed they didnt fight harder, or negotiated some deal with big pharma to get them to butter up the greasy sticky hands of the FDA.

Meanwhile, Alzheimers afflicted families and carers continue with the burden of caring after cognitive degrading loved ones. There is 6 million Alzheimer patients in US alone , quite staggering as the article pointed out, and stated that 2 carers are needed per patient ( 12 million carers is a big number! )